Patents by Inventor Elizabeth Petri Henske

Elizabeth Petri Henske has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140050665
    Abstract: Treatment of lymphangioleiomyomatosis with the MEK1/2 inhibitor CI-1040 delayed the development of primary tumors and blocked the estrogen-induced lung metastases in treated animals. Such treatment also reduced the number of circulating ELT3 cells and decreased their lung colonization after intravenous injection.
    Type: Application
    Filed: August 9, 2013
    Publication date: February 20, 2014
    Applicant: Fox Chase Cancer Center
    Inventors: Elizabeth Petri HENSKE, Jane YU
  • Patent number: 8530457
    Abstract: Treatment of lymphangioleiomyomatosis with the MEK1/2 inhibitor CI-1040 delayed the development of primary tumors and blocked the estrogen-induced lung metastases in treated animals. Such treatment also reduced the number of circulating ELT3 cells and decreased their lung colonization after intravenous injection.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: September 10, 2013
    Assignee: Fox Chase Cancer Center
    Inventors: Elizabeth Petri Henske, Jane Yu